Reply: Economic Impacts Associated With Recombinant Bovine Somatotropin (rBST) Use
Metadata[+] Show full item record
Losinger's criticism of our paper pertains to the following key points: the use of national estimates, the functional form employed, making multiple uses of the model, not considering all the costs, and the use of NAHMS data for economic analysis. We briefly address each one below.
AgBioForum, 5(2) 2002: 28-29.